Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Veronika Farkasova"'
Autor:
Peter Galis, Linda Bartosova, Veronika Farkasova, Monika Bartekova, Kristina Ferenczyova, Tomas Rajtik
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
Diabetic cardiomyopathy (DCM) is a severe secondary complication of type 2 diabetes mellitus (T2DM) that is diagnosed as a heart disease occurring in the absence of any previous cardiovascular pathology in diabetic patients. Although it is still lack
Externí odkaz:
https://doaj.org/article/aab9e7ede8b746cf993db99a965a5e48
Autor:
Tanya Ravingerova, Adriana Adameova, Lubomir Lonek, Veronika Farkasova, Miroslav Ferko, Natalia Andelova, Branislav Kura, Jan Slezak, Eleftheria Galatou, Antigone Lazou, Vladislava Zohdi, Naranjan S. Dhalla
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16497 (2023)
Cardiovascular diseases, especially ischemic heart disease, as a leading cause of heart failure (HF) and mortality, will not reduce over the coming decades despite the progress in pharmacotherapy, interventional cardiology, and surgery. Although pati
Externí odkaz:
https://doaj.org/article/982db32fb9d241019143a6d73b43eb5f
Autor:
Lucia Kindernay, Veronika Farkasova, Jan Neckar, Jaroslav Hrdlicka, Kirsti Ytrehus, Tanya Ravingerova
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 20, p 11009 (2021)
Aging attenuates cardiac tolerance to ischemia/reperfusion (I/R) associated with defects in protective cell signaling, however, the onset of this phenotype has not been completely investigated. This study aimed to compare changes in response to I/R a
Externí odkaz:
https://doaj.org/article/0c4d4637159547e9a8c3d2e637cf6557
Autor:
Kristina Ferenczyova, Barbora Kalocayova, Lucia Kindernay, Marek Jelemensky, Peter Balis, Andrea Berenyiova, Anna Zemancikova, Veronika Farkasova, Matus Sykora, Lubomira Tothova, Tomas Jasenovec, Jana Radosinska, Jozef Torok, Sona Cacanyiova, Miroslav Barancik, Monika Bartekova
Publikováno v:
Molecules, Vol 25, Iss 1, p 187 (2020)
Background: Quercetin (QCT) was shown to exert beneficial cardiovascular effects in young healthy animals. The aim of the present study was to determine cardiovascular benefits of QCT in older, 6-month and 1-year-old Zucker diabetic fatty (ZDF) rats
Externí odkaz:
https://doaj.org/article/51026863fc894b47b8624c6e4b3b867d
Autor:
Peter Galis, Linda Bartosova, Veronika Farkasova, Adrian Szobi, Csaba Horvath, Dominika Kovacova, Adriana Adameova, Tomas Rajtik
Publikováno v:
Cardiovascular Toxicology.
Autor:
Monika Bartekova, Andrea Berenyiova, Lucia Kindernay, Veronika Farkasova, Barbora Kalocayova, Sona Cacanyiova, Miroslav Barancik, Jana Radosinska, Marek Jelemensky, Kristina Ferenczyova, Anna Zemancikova, Peter Balis, Jozef Török, Lubomira Tothova, Tomas Jasenovec, Matus Sykora
Publikováno v:
Molecules
Molecules, Vol 25, Iss 1, p 187 (2020)
Volume 25
Issue 1
Molecules, Vol 25, Iss 1, p 187 (2020)
Volume 25
Issue 1
Background: Quercetin (QCT) was shown to exert beneficial cardiovascular effects in young healthy animals. The aim of the present study was to determine cardiovascular benefits of QCT in older, 6-month and 1-year-old Zucker diabetic fatty (ZDF) rats
Autor:
Táňa Ravingerová, Adriana Adameova, Vinoth Kumar Megraj Khandelwal, Veronika Farkasova, Antigone Lazou, Frantisek Kolar, L. Griecsova, M Ferko, M Zálešák, Jan Slezak, S Carnicka, M Murarikova, L. Lonek
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 95:1204-1212
Currently, there are no satisfactory interventions to protect the heart against the detrimental effects of ischemia–reperfusion injury. Although ischemic preconditioning (PC) is the most powerful form of intrinsic cardioprotection, its application
Autor:
Adrian Szobi, Tatiana Ravingerova, Jan Neckar, Adriana Adameova, M Murarikova, Naranjan S. Dhalla, Jaroslav Hrdlička, Frantisek Kolar, Katarina Kopaskova, Veronika Farkasova
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 95:1163-1169
Long-lasting ischemia can result in cell loss; however, repeated episodes of brief ischemia increase the resistance of the heart against deleterious effects of subsequent prolonged ischemic insult and promote cell survival. Traditionally, it is belie
Publikováno v:
Canadian Journal of Physiology and Pharmacology. 95:888-893
Generation of free radicals through incomplete reduction of oxygen during ischemia–reperfusion (I/R) is well described. On the other hand, molecular hydrogen (H2) reduces oxidative stress due to its ability to react with strong oxidants and easily
Autor:
Daniela Jezova, Lucia Balagova, L. Lonek, Agnesa Puhova, L. Griecsova, Sagar P. Patel, Tana Ravingerova, Veronika Farkasova
Publikováno v:
Pathophysiology. 25:181-182